Kent U M, Bend J R, Chamberlin B A, Gage D A, Hollenberg P F
Department of Pharmacology, The University of Michigan, Ann Arbor 48109, USA.
Chem Res Toxicol. 1997 May;10(5):600-8. doi: 10.1021/tx960184o.
The kinetics of inactivation of cytochrome P450 2B1, the major phenobarbital inducible rat hepatic P450, by N-benzyl-1-aminobenzotriazole (BBT) were characterized. Purified, reconstituted P450 2B1 7-ethoxy-4-(trifluoromethyl)coumarin (7-EFC) O-deethylase activity was inhibited by BBT in a mechanism-based manner. The loss of O-deethylase activity followed pseudo-first-order kinetics and was NADPH and BBT dependent. After a 5 min incubation, greater than 90% of the 2B1 activity was lost, whereas more than 70% of the ability of the reduced enzyme to bind CO was maintained. Inclusion of 10 mM glutathione in the inactivation reaction lowered the rate of inactivation (k(inactivation)) and increased the partition ratio without significantly affecting the inactivator concentration required for half-maximal inactivation (K(I)). The maximal rate constant for inactivation at 23 degrees C was 0.24 min(-1) without and 0.15 min(-1) with glutathione. The apparent K(I) was 2 microM in both cases. The extrapolated partition ratios were 4 and 9 without and with 10 mM glutathione, respectively. Consistent with mechanism-based inactivation, the loss of 7-EFC O-deethylase activity was irreversible, was not due to product inhibition, was saturable, and could be slowed by including increasing concentrations of competing substrate. However, the inactivated P450 2B1 was still able to metabolize substrate if iodosobenzene was used as an alternate oxidant. Inactivation of 2B1 with either N-[14C]-7-benzyl-1-aminobenzotriazole (BBT) or N-benzyl-1-amino-[14C]-2,3-benzotriazole resulted in the incorporation of covalent radiolabel into the apoprotein. The stoichiometry of labeled metabolite adduct to protein was approximately 0.4:1 in both cases. Identification of metabolites revealed the formation of 1-aminobenzotriazole, benzotriazole, benzaldehyde, and a new metabolite (27) during catalysis of BBT by P450 2B1. Together, these data suggest that P450 2B1 could be inactivated and labeled by more than one metabolite.
对N-苄基-1-氨基苯并三唑(BBT)使细胞色素P450 2B1(主要的苯巴比妥诱导型大鼠肝脏P450)失活的动力学进行了表征。纯化并重组的P450 2B1 7-乙氧基-4-(三氟甲基)香豆素(7-EFC)O-脱乙基酶活性以基于机制的方式被BBT抑制。O-脱乙基酶活性的丧失遵循准一级动力学,且依赖于NADPH和BBT。孵育5分钟后,超过90%的2B1活性丧失,而还原型酶与CO结合的能力仍保持70%以上。在失活反应中加入10 mM谷胱甘肽可降低失活速率(k(失活))并增加分配比,而不会显著影响半最大失活所需的失活剂浓度(K(I))。23℃下无谷胱甘肽时失活的最大速率常数为0.24 min⁻¹,有谷胱甘肽时为0.15 min⁻¹。两种情况下表观K(I)均为2 μM。无谷胱甘肽和有10 mM谷胱甘肽时外推的分配比分别为4和9。与基于机制的失活一致,7-EFC O-脱乙基酶活性的丧失是不可逆的,不是由于产物抑制,是可饱和的,并且可以通过增加竞争性底物的浓度来减缓。然而,如果使用亚碘酰苯作为替代氧化剂,失活的P450 2B1仍能够代谢底物。用N-[¹⁴C]-7-苄基-1-氨基苯并三唑(BBT)或N-苄基-1-氨基-[¹⁴C]-2,3-苯并三唑使2B1失活,导致共价放射性标记掺入脱辅基蛋白中。两种情况下标记代谢物加合物与蛋白质的化学计量比均约为0.4:1。代谢物鉴定显示,在P450 2B1催化BBT的过程中形成了1-氨基苯并三唑、苯并三唑、苯甲醛和一种新的代谢物(27)。总之,这些数据表明P450 2B1可能被不止一种代谢物失活和标记。